ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1800

Macrophages in Hypoxic Rheumatoid Joints Preferentially Express Hypoxia Inducible Transcription Factor-2

Sarah Aynsley1, Ursula Fearon2, Anthony G. Wilson1 and Munitta Muthana3, 1Infection and Immunity, University of Sheffield, Sheffield, United Kingdom, 2Rheumatology, Translation Research Group, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 3Infection and Immunity, University of sheffield, Sheffield, United Kingdom

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: macrophages

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, and Gene Regulation

Session Type: Abstract Submissions (ACR)

Background/Purpose:

In rheumatoid arthritis (RA), the influx of inflammatory cells as well as the aggressive proliferation of fibroblast-like synovial cells (FLS) outstrips the oxygen supply from blood vessels leading to joint hypoxia.  Macrophages accumulate in hypoxic disease sites including RA joints where they possess broad pro-inflammatory, destructive and remodeling potential leading to inflammation and joint destruction. Macrophages respond to hypoxia by up regulating the hypoxia inducible transcription factors– HIF-1 and -2 normally degraded in the presence of oxygen. This study will attempt to understand the relative contribution of HIF-1 and HIF-2 expressing macrophages in RA and the genes/mechanisms involved in their activation.

Methods:

We obtained arthroscopy sections from RA patients for which tissue oxygen levels had been measured. This consisted of a random sample of mild (~40mmHg), moderate (~15mmHg) & severe (~3mmHg) joint hypoxia. We also used samples from a second cohort of patients scored with mild or severe disease (based upon extent of synovitis and vascularity), a sub group of which were also receiving anti-TNF therapy. Sections were immunostained with anti-HIF 1 and 2 and co-localised with the pan-macrophage marker CD68 as well as other macrophage markers (Flt-1, CD147, CD206 and Tie2).

Results:

In patients with mildly hypoxic joints, macrophages (CD68+) predominately expressed HIF-1 (20%) and CD147 and were found in small clusters localised to the lining layer, whilst macrophages in patients with severely hypoxic joints were in greater numbers (73%), throughout the biopsy. These macrophages predominately expressed HIF-2+ (>75%), Flt-1, Tie2 and CD206. A similar pattern was observed in patients with severe disease where sections expressed more HIF-2+Flt-1+ macrophages compared to those with mild scores (15 cells per field of view compared to 5 for mild p<0.01). There was no significant difference in HIF-1 expression.  Interestingly, this HIF-2+ macrophage subpopulation was absent in patients who had been successfully treated with anti-TNF.

Conclusion:

In patients with severely hypoxic joints macrophage numbers were significantly greater than in patients with mild hypoxia and predominantly expressed HIF-2+, which activates genes associated with both inflammation and angiogenesis. These cells expressed M2-like macrophage markers including Flt-1, Tie2 & CD206, important in tissue remodeling and angiogenesis. We are currently investigating the gene expression profile of these subpopulations using laser capture micro-dissection and gene arrays and will further study their relevance in animal models of RA using transgenic mice with targeted deletions of HIF-1 or HIF-2 in myeloid cells.


Disclosure:

S. Aynsley,
None;

U. Fearon,
None;

A. G. Wilson,
None;

M. Muthana,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/macrophages-in-hypoxic-rheumatoid-joints-preferentially-express-hypoxia-inducible-transcription-factor-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology